You are here

IBD

A new biotech tackling IBD joins a race against Lilly and Gilead for a promising pill

Pharma Voice

Thu, 07/18/24 - 11:12 am

Ensho Therapeutics

Gilead Sciences

Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster

Fierce Biotech

Mon, 07/8/24 - 11:54 am

AbbVie inks immune disorder drug licensing deal with China's FutureGen

Reuters

Thu, 06/13/24 - 11:07 am

Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?

Motley Fool

Sun, 10/29/23 - 08:44 pm

ulcerative colitis

Crohn's Disease

Roche pays $7.1B to Roivant for rights to Telavant’s IBD candidate

BioSpace

Mon, 10/23/23 - 10:35 am

ulcerative colitis

Crohn’s disease

Sanofi pays Teva $500M to join Merck, Roivant in red-hot bowel disease race

Fierce Biotech

Wed, 10/4/23 - 09:48 am

Teva Pharmaceutical

inflammatory bowl disease

Celltrion presents infliximab data at ECCO Congress

Clinical Trials Arena

Wed, 07/5/23 - 10:26 am

AstraZeneca Teams Up With Startup Quell in Type 1 Diabetes, IBD Cell Therapy Pact

MedCity News

Fri, 06/9/23 - 11:52 am

Quell Therapeutics

type 1 diabetes

AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral

Fierce Biotech

Thu, 06/1/23 - 11:41 am

Why Did Pfizer Offload This Potential Mega-Blockbuster Drug?

Motley Fool

Mon, 04/24/23 - 10:18 am

Merck to buy inflammatory disease drugmaker Prometheus for $10.8B

BioPharma Dive

Sun, 04/16/23 - 11:31 pm

Prometheus Biosciences

FDA declines to approve Eli Lilly's bowel disease drug

Yahoo/Reuters

Thu, 04/13/23 - 10:19 pm

AbbVie's Skyrizi aces ulcerative colitis study en route to new IBD showdown with J&J, Takeda

Fierce Pharma

Thu, 03/23/23 - 11:39 am

ulcerative colitis

clinical trials

Roivant’s Matt Gline on the hub-and-spoke biotech model and lessons learned from Axovant

Biopharma Dive

Mon, 01/23/23 - 09:45 pm

Roivant Sciences

Sanofi and CytoReason target IBD in expanded collaboration

Pharma Live

Mon, 01/23/23 - 11:03 am

Satisfai, Virgo, and Alimentiv to boost trials using AI-powered technology

Clinical Trials Arena

Thu, 10/6/22 - 10:55 am

Satisfai Health

Virgo Surgical Video Solutions

clinical trials

artificial intelligence

Nestlé wagers $41M on Enterome's preclinical food allergy and IBD prospect

Fierce Biotech

Mon, 07/18/22 - 10:00 am

Boehringer Ingelheim and BiomX Collaborate to Discover Inflammatory Bowel Disease Microbiome Biomarkers

BioSpace

Tue, 06/28/22 - 10:40 am

Boehringer Ingelheim

Celsius Therapeutics heats up with $83M and an IBD drug on path to the clinic

MedCity News

Thu, 03/24/22 - 08:37 pm

Celsius Therapeutics

Using CRISPR to find a new drug target for multiple sclerosis, inflammatory bowel disease

Fierce Biotech

Sun, 11/14/21 - 10:52 pm

multiple sclerosis

Pages